211 related articles for article (PubMed ID: 11939414)
21. Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth.
Loeffler M; Le'Negrate G; Krajewska M; Reed JC
Cancer Immunol Immunother; 2009 May; 58(5):769-75. PubMed ID: 18633610
[TBL] [Abstract][Full Text] [Related]
22. Tumor-specific delivery of histidine-rich glycoprotein suppresses tumor growth and metastasis by anti-angiogenesis and vessel normalization.
Cheng X; Zhang X; Cheng W; Chen J; Ma C; Yang B; Hua ZC
Curr Gene Ther; 2014; 14(2):75-85. PubMed ID: 24606115
[TBL] [Abstract][Full Text] [Related]
23. Intratumoral injection of schwannoma with attenuated
Ahmed SG; Oliva G; Shao M; Wang X; Mekalanos JJ; Brenner GJ
Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2202719119. PubMed ID: 35675425
[TBL] [Abstract][Full Text] [Related]
24. Effect of Salmonella enterica serovar Typhimurium VNP20009 and VNP20009 with restored chemotaxis on 4T1 mouse mammary carcinoma progression.
Coutermarsh-Ott SL; Broadway KM; Scharf BE; Allen IC
Oncotarget; 2017 May; 8(20):33601-33613. PubMed ID: 28431394
[TBL] [Abstract][Full Text] [Related]
25. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
26. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
27. Culture of attenuated
Ahmed SG; Oliva G; Shao M; Mekalanos JJ; Brenner GJ
Hum Vaccin Immunother; 2023 Aug; 19(2):2262639. PubMed ID: 37786375
[TBL] [Abstract][Full Text] [Related]
28. Salmonella-mediated tumor-targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model.
Chen J; Yang B; Cheng X; Qiao Y; Tang B; Chen G; Wei J; Liu X; Cheng W; Du P; Huang X; Jiang W; Hu Q; Hu Y; Li J; Hua ZC
Cancer Sci; 2012 Feb; 103(2):325-33. PubMed ID: 22054098
[TBL] [Abstract][Full Text] [Related]
29. Microwave ablation combined with attenuated Salmonella typhimurium for treating hepatocellular carcinoma in a rat model.
Zhao Q; Qu X; Liu K; Shi H; Yang G; Zhou B; Zhu L; Zhang W; Yan Z; Liu R; Qian S; Wang J
Oncotarget; 2017 Jul; 8(29):47655-47664. PubMed ID: 28498813
[TBL] [Abstract][Full Text] [Related]
30. Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapy.
Liang K; Liu Q; Li P; Luo H; Wang H; Kong Q
Cancer Lett; 2019 Apr; 448():168-181. PubMed ID: 30753837
[TBL] [Abstract][Full Text] [Related]
31. Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice.
Waud WR; Plowman J; Harrison SD; Dykes DJ; Anderson WK; Griswold DP
Cancer Chemother Pharmacol; 1992; 30(4):261-6. PubMed ID: 1322803
[TBL] [Abstract][Full Text] [Related]
32. Potentiating bacterial cancer therapy using hydroxychloroquine liposomes.
Wang Y; Zhou Z; Chen W; Qin M; Zhang Z; Gong T; Sun X
J Control Release; 2018 Jun; 280():39-50. PubMed ID: 29730153
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4.
Kolber DL; Knisely TL; Maione TE
J Natl Cancer Inst; 1995 Feb; 87(4):304-9. PubMed ID: 7707422
[TBL] [Abstract][Full Text] [Related]
34. Enhanced therapeutic effect of an antiangiogenesis peptide on lung cancer in vivo combined with salmonella VNP20009 carrying a Sox2 shRNA construct.
Zhao C; He J; Cheng H; Zhu Z; Xu H
J Exp Clin Cancer Res; 2016 Jul; 35(1):107. PubMed ID: 27371094
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
[TBL] [Abstract][Full Text] [Related]
36. Immunotherapy of a plasmacytoma with attenuated salmonella.
Eisenstein TK; Bushnell B; Meissler JJ; Dalal N; Schafer R; Havas HF
Med Oncol; 1995 Jun; 12(2):103-8. PubMed ID: 8535659
[TBL] [Abstract][Full Text] [Related]
37. Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium.
Rosenberg SA; Spiess PJ; Kleiner DE
J Immunother; 2002; 25(3):218-25. PubMed ID: 12000863
[TBL] [Abstract][Full Text] [Related]
38. Optimizing the restored chemotactic behavior of anticancer agent Salmonella enterica serovar Typhimurium VNP20009.
Broadway KM; Suh S; Behkam B; Scharf BE
J Biotechnol; 2017 Jun; 251():76-83. PubMed ID: 28433721
[TBL] [Abstract][Full Text] [Related]
39. Suppression of pancreatic ductal adenocarcinoma growth by intratumoral delivery of attenuated Salmonella typhimurium using a dual fluorescent live tracking system.
Zhou S; Zhao Z; Lin Y; Gong S; Li F; Pan J; Li X; Gao Z; Zhao AZ
Cancer Biol Ther; 2016 Jul; 17(7):732-40. PubMed ID: 27089121
[TBL] [Abstract][Full Text] [Related]
40. Effects of cytochalasin B in culture and in vivo on murine Madison 109 lung carcinoma and on B16 melanoma.
Bousquet PF; Paulsen LA; Fondy C; Lipski KM; Loucy KJ; Fondy TP
Cancer Res; 1990 Mar; 50(5):1431-9. PubMed ID: 2302708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
